Table 1.

Baseline characteristics of the study population

CharacteristicTotal population (N =12062)
Age, years (n =12 062)67.0 ± 10.7
Sex, women (n =12 062)7077 (58.7%)
BMI, kg/m2 (n =9829)27.2 ± 4.2
Smoking, n (valid %) (n =10 052)
 Never3293 (32.8%)
 Past4802 (47.8%)
 Current1957 (19.5%)
Alcohol, g/day (n =8272)5.7 (0.5–14.3)
Serum cholesterol, mmol/L (n =9871)5.7 ± 1.0
Serum triglyceride, mmol/L (n =9902)1.5 ± 0.8
Systolic blood pressure, mmHg (n =9927)140 ± 21
Diastolic blood pressure, mmHg (n =9927)79 ± 12
Hypertension, n (valid %) (n =9902)6250 (63.1%)
Diabetes, n (valid %) (n =10 337)1246 (12.1%)
History of CVD, n (valid %) (n =10 286)865 (8.4%)
Use of antihypertensive medication (n =9796)3267 (33.4%)
Use of lipid-lowering medication (n =10 920)1780 (16.3%)
Use of cardiac medication (n =10 920)895 (8.2%)
CharacteristicTotal population (N =12062)
Age, years (n =12 062)67.0 ± 10.7
Sex, women (n =12 062)7077 (58.7%)
BMI, kg/m2 (n =9829)27.2 ± 4.2
Smoking, n (valid %) (n =10 052)
 Never3293 (32.8%)
 Past4802 (47.8%)
 Current1957 (19.5%)
Alcohol, g/day (n =8272)5.7 (0.5–14.3)
Serum cholesterol, mmol/L (n =9871)5.7 ± 1.0
Serum triglyceride, mmol/L (n =9902)1.5 ± 0.8
Systolic blood pressure, mmHg (n =9927)140 ± 21
Diastolic blood pressure, mmHg (n =9927)79 ± 12
Hypertension, n (valid %) (n =9902)6250 (63.1%)
Diabetes, n (valid %) (n =10 337)1246 (12.1%)
History of CVD, n (valid %) (n =10 286)865 (8.4%)
Use of antihypertensive medication (n =9796)3267 (33.4%)
Use of lipid-lowering medication (n =10 920)1780 (16.3%)
Use of cardiac medication (n =10 920)895 (8.2%)

Data are presented as number (%), mean ± SD or median (interquartile range). Values are given for non-imputed data. The n represents the number of participants without missing data. BMI, body mass index; CVD, cardiovascular disease; n, number.

Table 1.

Baseline characteristics of the study population

CharacteristicTotal population (N =12062)
Age, years (n =12 062)67.0 ± 10.7
Sex, women (n =12 062)7077 (58.7%)
BMI, kg/m2 (n =9829)27.2 ± 4.2
Smoking, n (valid %) (n =10 052)
 Never3293 (32.8%)
 Past4802 (47.8%)
 Current1957 (19.5%)
Alcohol, g/day (n =8272)5.7 (0.5–14.3)
Serum cholesterol, mmol/L (n =9871)5.7 ± 1.0
Serum triglyceride, mmol/L (n =9902)1.5 ± 0.8
Systolic blood pressure, mmHg (n =9927)140 ± 21
Diastolic blood pressure, mmHg (n =9927)79 ± 12
Hypertension, n (valid %) (n =9902)6250 (63.1%)
Diabetes, n (valid %) (n =10 337)1246 (12.1%)
History of CVD, n (valid %) (n =10 286)865 (8.4%)
Use of antihypertensive medication (n =9796)3267 (33.4%)
Use of lipid-lowering medication (n =10 920)1780 (16.3%)
Use of cardiac medication (n =10 920)895 (8.2%)
CharacteristicTotal population (N =12062)
Age, years (n =12 062)67.0 ± 10.7
Sex, women (n =12 062)7077 (58.7%)
BMI, kg/m2 (n =9829)27.2 ± 4.2
Smoking, n (valid %) (n =10 052)
 Never3293 (32.8%)
 Past4802 (47.8%)
 Current1957 (19.5%)
Alcohol, g/day (n =8272)5.7 (0.5–14.3)
Serum cholesterol, mmol/L (n =9871)5.7 ± 1.0
Serum triglyceride, mmol/L (n =9902)1.5 ± 0.8
Systolic blood pressure, mmHg (n =9927)140 ± 21
Diastolic blood pressure, mmHg (n =9927)79 ± 12
Hypertension, n (valid %) (n =9902)6250 (63.1%)
Diabetes, n (valid %) (n =10 337)1246 (12.1%)
History of CVD, n (valid %) (n =10 286)865 (8.4%)
Use of antihypertensive medication (n =9796)3267 (33.4%)
Use of lipid-lowering medication (n =10 920)1780 (16.3%)
Use of cardiac medication (n =10 920)895 (8.2%)

Data are presented as number (%), mean ± SD or median (interquartile range). Values are given for non-imputed data. The n represents the number of participants without missing data. BMI, body mass index; CVD, cardiovascular disease; n, number.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close